BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 9426521)

  • 1. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma.
    Wick MR; Ockner DM; Mills SE; Ritter JH; Swanson PE
    Am J Clin Pathol; 1998 Jan; 109(1):75-84. PubMed ID: 9426521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
    Wallace ML; Longacre TA; Smoller BR
    Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gross cystic disease fluid protein-15 in salivary gland tumors.
    Swanson PE; Pettinato G; Lillemoe TJ; Wick MR
    Arch Pathol Lab Med; 1991 Feb; 115(2):158-63. PubMed ID: 1992983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential sensitivity of estrogen/progesterone receptors and BRST-2 markers in metastatic ductal and lobular breast carcinoma to the skin.
    Wallace ML; Smoller BR
    Am J Dermatopathol; 1996 Jun; 18(3):241-7. PubMed ID: 8806958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
    Gatalica Z
    Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
    Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT
    Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue.
    Satoh F; Umemura S; Osamura RY
    Breast Cancer; 2000 Jan; 7(1):49-55. PubMed ID: 11029771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic breast tissue and breast-like sweat gland metaplasias: an overlapping spectrum of lesions.
    Pfeifer JD; Barr RJ; Wick MR
    J Cutan Pathol; 1999 Apr; 26(4):190-6. PubMed ID: 10335896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases.
    Wong TY; Suster S; Cheek RF; Mihm MC
    Am J Dermatopathol; 1996 Apr; 18(2):124-36. PubMed ID: 8739986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma.
    Kapadia SB; Barnes L
    Mod Pathol; 1998 Nov; 11(11):1033-8. PubMed ID: 9831198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
    Radhi JM
    Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation.
    Ansai S; Koseki S; Hozumi Y; Kondo S
    Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apocrine adenocarcinoma of the bilateral axillae.
    Yoshida A; Kodama Y; Hatanaka S; Takasaki T; Kuriwaki K; Yoshida H
    Acta Pathol Jpn; 1991 Dec; 41(12):927-32. PubMed ID: 1785351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant eccrine spiradenoma. A clinicopathologic study.
    Argenyi ZB; Nguyen AV; Balogh K; Sears JK; Whitaker DC
    Am J Dermatopathol; 1992 Oct; 14(5):381-90. PubMed ID: 1384379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal carcinoma in situ of the breast: correlation between histologic classifications and biologic markers.
    Moreno A; Lloveras B; Figueras A; Escobedo A; Ramon JM; Sierra A; Fabra A
    Mod Pathol; 1997 Nov; 10(11):1088-92. PubMed ID: 9388058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syringoid eccrine carcinoma: a case report.
    Malmusi M; Collina G
    Am J Dermatopathol; 1997 Oct; 19(5):533-5. PubMed ID: 9335248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
    Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
    J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical correlates of morphologic differentiation in human breast cancer.
    Silva JS; Cox CE; Wells SA; Paull D; Dilley WG; McCarty KS; Fetter BF; Glaubitz LC; McCarty KS
    Surgery; 1982 Sep; 92(3):443-9. PubMed ID: 7202259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucinous carcinoma of the eyelid. An immunohistochemical study.
    Carson HJ; Gattuso P; Raslan WF; Reddy V
    Am J Dermatopathol; 1995 Oct; 17(5):494-8. PubMed ID: 8599456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites.
    Kaufmann O; Deidesheimer T; Muehlenberg M; Deicke P; Dietel M
    Histopathology; 1996 Sep; 29(3):233-40. PubMed ID: 8884351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.